v3.25.4
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Feb. 06, 2026
Document and Entity Information [Abstract]    
Document Type 10-K  
Document Annual Report true  
Document Period End Date Dec. 31, 2025  
Document Transition Report false  
Entity File Number 001-41264  
Entity Registrant Name NUVECTIS PHARMA, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 86-2405608  
Entity Address, Address Line One 1 Bridge Plaza  
Entity Address, Address Line Two Suite 275  
Entity Address, City or Town Fort Lee  
Entity Address State Or Province NJ  
Entity Address, Postal Zip Code 07024  
City Area Code 201  
Local Phone Number 614-3150  
Title of 12(b) Security Common Stock, par value $0.00001 per  
Trading Symbol NVCT  
Security Exchange Name NASDAQ  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
ICFR Auditor Attestation Flag false  
Document Financial Statement Error Correction Flag false  
Entity Shell Company false  
Entity Public Float $ 100.0  
Entity Common Stock, Shares Outstanding   26,491,702
Entity Central Index Key 0001875558  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus FY  
Amendment Flag false  
Auditor Name PricewaterhouseCoopers International Limited  
Auditor Location Tel-Aviv, Israel  
Auditor Firm ID 1309